Systematic Synthesis and Binding Study of HIV V3 Glycopeptides Reveal the Fine Epitopes of Several Broadly Neutralizing Antibodies
|
journal
|
April 2017 |
Altering the Specificity of the Antibody Response to HIV gp120 with a Glycoconjugate Antigen
|
journal
|
April 2016 |
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
|
journal
|
November 2011 |
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
|
journal
|
January 2016 |
Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16
|
journal
|
May 2013 |
The effect of Fc glycan forms on human IgG2 antibody clearance in humans
|
journal
|
November 2008 |
N-glycan PK Profiling Using a High Sensitivity nanoLCMS Work-Flow with Heavy Stable Isotope Labeled Internal Standard and Application to a Preclinical Study of an IgG1 Biopharmaceutical
|
journal
|
May 2015 |
Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans
|
journal
|
May 2013 |
Broad neutralization coverage of HIV by multiple highly potent antibodies
|
journal
|
September 2011 |
Announcing the worldwide Protein Data Bank
|
journal
|
December 2003 |
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
|
journal
|
March 2016 |
Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers
|
journal
|
May 2014 |
Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors
|
journal
|
October 2013 |
A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity
|
journal
|
September 2010 |
Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12
|
journal
|
September 2005 |
Toward a Carbohydrate-Based HIV-1 Vaccine: Synthesis and Immunological Studies of Oligomannose-Containing Glycoconjugates
|
journal
|
March 2006 |
Structure and Immune Recognition of the HIV Glycan Shield
|
journal
|
May 2018 |
An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions
|
journal
|
October 2008 |
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
|
journal
|
July 2010 |
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
|
journal
|
September 2013 |
Synthesis of multivalent glycopeptide conjugates that mimic an HIV epitope
|
journal
|
October 2016 |
Characterization of a soluble class I α-mannosidase in human serum
|
journal
|
April 1999 |
Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity
|
journal
|
November 2017 |
Proof of principle for epitope-focused vaccine design
|
journal
|
February 2014 |
Chemical Synthesis of Highly Congested gp120 V1V2 N -Glycopeptide Antigens for Potential HIV-1-Directed Vaccines
|
journal
|
August 2013 |
A Blueprint for HIV Vaccine Discovery
|
journal
|
October 2012 |
Unprecedented Role of Hybrid N- Glycans as Ligands for HIV-1 Broadly Neutralizing Antibodies
|
journal
|
March 2018 |
Production, characterization and pharmacokinetic properties of antibodies with N-linked Mannose-5 glycans
|
journal
|
July 2012 |
Site-Selective Chemoenzymatic Glycosylation of an HIV-1 Polypeptide Antigen with Two Distinct N-Glycans via an Orthogonal Protecting Group Strategy
|
journal
|
July 2016 |
Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
|
journal
|
October 2016 |
Antibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Nondomain-Exchanged Forms but Only Binds the HIV-1 Glycan Shield if Domain Exchanged
|
journal
|
August 2010 |
A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective “Ligation” of Azides and Terminal Alkynes
|
journal
|
July 2002 |
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates
|
journal
|
February 2017 |
Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation
|
journal
|
May 2018 |
Fully Synthetic Carbohydrate HIV Antigens Designed on the Logic of the 2G12 Antibody
|
journal
|
September 2007 |
HIV-1 neutralizing antibodies induced by native-like envelope trimers
|
journal
|
June 2015 |
Transplanting Supersites of HIV-1 Vulnerability
|
journal
|
July 2014 |
SELMA: Selection with Modified Aptamers
|
journal
|
June 2015 |
Antibody responses to envelope glycoproteins in HIV-1 infection
|
journal
|
May 2015 |
Very Few Substitutions in a Germ Line Antibody Are Required To Initiate Significant Domain Exchange
|
journal
|
August 2010 |
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
|
journal
|
March 2016 |
Cross-Clade HIV-1 Neutralizing Antibodies Induced with V3-Scaffold Protein Immunogens following Priming with gp120 DNA
|
journal
|
July 2011 |
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies
|
journal
|
August 2016 |
Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans
|
journal
|
September 2015 |
Synthetic multivalent V3 glycopeptides display enhanced recognition by glycan-dependent HIV-1 broadly neutralizing antibodies
|
journal
|
January 2017 |
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein
|
journal
|
March 2016 |
Antibody recognition of HIV and dengue glycoproteins
|
journal
|
March 2016 |
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
|
journal
|
June 2003 |
Overview of the development and current use of CRM197 conjugate vaccines for pediatric use
|
journal
|
June 2010 |
Defining Criteria for Oligomannose Immunogens for HIV Using Icosahedral Virus Capsid Scaffolds
|
journal
|
April 2010 |
Synthetic Three-Component HIV-1 V3 Glycopeptide Immunogens Induce Glycan-Dependent Antibody Responses
|
journal
|
December 2017 |
Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer
|
journal
|
January 2013 |
The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade
|
journal
|
August 2011 |
Hyperglycosylated Stable Core Immunogens Designed To Present the CD4 Binding Site Are Preferentially Recognized by Broadly Neutralizing Antibodies
|
journal
|
December 2014 |
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
|
journal
|
June 2017 |
Yeast-Elicited Cross-Reactive Antibodies to HIV Env Glycans Efficiently Neutralize Virions Expressing Exclusively High-Mannose N-Linked Glycans
|
journal
|
October 2010 |
Dynamics of B cells in germinal centres
|
journal
|
February 2015 |
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
|
journal
|
October 2012 |
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
|
journal
|
October 2011 |
Directed Evolution of 2G12‐Targeted Nonamannose Glycoclusters by SELMA
|
journal
|
November 2013 |
Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies
|
journal
|
September 2014 |
Structure of 2G12 Fab2 in Complex with Soluble and Fully Glycosylated HIV-1 Env by Negative-Stain Single-Particle Electron Microscopy
|
journal
|
June 2014 |
Recent strategies targeting HIV glycans in vaccine design
|
journal
|
November 2014 |
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
|
journal
|
May 2013 |
Multivalent Glycocluster Design through Directed Evolution
|
journal
|
October 2011 |
Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies
|
journal
|
June 2013 |
An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides
|
journal
|
October 2007 |
Directed Evolution of Multivalent Glycopeptides Tightly Recognized by HIV Antibody 2G12
|
journal
|
February 2014 |
High Temperature SELMA: Evolution of DNA-Supported Oligomannose Clusters Which Are Tightly Recognized by HIV bnAb 2G12
|
journal
|
January 2014 |
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
|
journal
|
March 2017 |
A Glycoconjugate Antigen Based on the Recognition Motif of a Broadly Neutralizing Human Immunodeficiency Virus Antibody, 2G12, Is Immunogenic but Elicits Antibodies Unable To Bind to the Self Glycans of gp120
|
journal
|
April 2008 |